(Q44724553)

5 December 2017

The comparative in vitro activity of ofloxacin and selected ophthalmic antimicrobial agents against ocular bacterial isolates (English)

1 reference

5 December 2017

1 reference

1 reference

M S Osato

1

1 reference

5 December 2017

H G Jensen

2

1 reference

5 December 2017

M D Trousdale

3

1 reference

5 December 2017

J A Bosso

4

1 reference

5 December 2017

L R Borrmann

5

1 reference

5 December 2017

J Frank

6

1 reference

5 December 2017

P Akers

7

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 October 1989

1 reference

American Journal of Ophthalmology

5 December 2017

1 reference

5 December 2017

108

1 reference

5 December 2017

4

1 reference

5 December 2017

380-386

1 reference

In vitro and in vivo activity of DL-8280, a new oxazine derivative

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973305-7

7 January 2021

The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973305-7

7 January 2021

In-vitro activity of ofloxacin, a quinolone carboxylic acid compared to other quinolones and other antimicrobial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973305-7

7 January 2021

Comparative in vitro antibacterial activity of ofloxacin and ciprofloxacin against some selected gram-positive and gram-negative isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973305-7

7 January 2021

Antibacterial activity of ofloxacin and its mode of action

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973305-7

7 January 2021

Comparative activity of ofloxacin and seven other antimicrobials against urea-splitting microorganisms.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973305-7

7 January 2021

Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973305-7

7 January 2021

Tobramycin in ophthalmology

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973305-7

7 January 2021

In vitro antibacterial activity of norfloxacin and other agents against ocular pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973305-7

7 January 2021

Potential of topical norfloxacin therapy. Comparative in vitro activity against clinical ocular bacterial isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973305-7

7 January 2021

10.1016/S0002-9394(14)73305-7

Identifiers

DOI

0 references

1 reference